MULTISITE ASSESSMENT OF THE IMPACT OF CELL-FREE DNA-BASED SCREENING FOR RARE AUTOSOMAL ANEUPLOIDIES ON PREGNANCY MANAGEMENT AND OUTCOMES

Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomes

Cell-free (cf) DNA screening is a noninvasive prenatal screening approach that is typically used to screen for common fetal trisomies, with optional screening for sex chromosomal aneuploidies and fetal sex.Genome-wide cfDNA screening can screen for a wide variety of additional anomalies, including rare autosomal aneuploidies (RAAs) and copy number

read more